Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 3
This trial is looking at an epidermal growth factor (EGF) vaccine for people with non small cell lung cancer that has spread to other parts of the body.
Recruitment start: 1 June 2016
Recruitment end: 6 March 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Marianne Nicolson
Bioven
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 15 June 2020
CRUK internal database number: 14172